Male Excel Testosterone Replacement Therapy Protocol

At Male Excel, we redefine healthcare by prioritizing how you feel and your symptoms over standardized numbers. When your primary physician labels your testosterone and other hormone levels as normal, we challenge this outlook and provide a fresh perspective on achieving the best quality of life.

How is Male Excel Different?


The Hormone Experts: What sets Male Excel apart from traditional healthcare providers is our dedicated team of experienced, highly trained TRT specialists. Unlike standard doctors, our providers have undergone rigorous training. They have extensive expertise in hormonal health, and are well-versed in the latest studies and advancements in the field. With Male Excel, you’re in good hands.*

*The Academy for Preventive and Innovative Medicine by Worldlink Medical and the Advanced Bio-Identical Hormone Replacement Therapy Certification (ABHRT)


Recognizing the Signs: We don’t ignore the signs of low testosterone. These include fatigue, low energy, weight issues, memory fog, low sex drive, and sleep disturbances. Low testosterone should be assessed primarily using symptoms. If you feel like you’ve got symptoms of low T, trust your instincts – you probably have.


Listen to Symptoms, Not Just Blood Work. When it comes to understanding your health, symptoms are your body’s way of speaking to you. They’re the messages your body sends to tell you something isn’t quite right. Instead of relying solely on blood test numbers, paying attention to these messages is crucial. We prioritize symptom-based treatment over blood levels.


Daily Injections For Maximum Benefit: Daily subcutaneous injections are the choice for precision hormone optimization. The daily regimen offers dependable and balanced testosterone delivery, negating the typical fluctuations in other methods. With far fewer side effects and improved hormone levels, the benefits and symptom relief are consistent and significant. Daily dosing is best.


Optimizing Thyroid Health: Our holistic approach assesses thyroid hormone levels alongside testosterone and symptoms. With optimum thyroid, you will see the actual benefits of testosterone replacement therapy. Thyroid has over 200 benefits in the body.


Estrogen’s Importance, Do NOT Block Estrogen: We emphasize the critical role of estrogen in men’s well-being, dispelling myths about blocking estrogen. Following advice to use estrogen blockers may pose severe risks, including Alzheimer’s, various cancers, and a swift path to Erectile Dysfunction. Men need estrogen to be healthy. Learn the truth about estrogen blockers.


Challenging the ‘Normal Range’: We challenge the limiting 300 ng/dL ‘normal range’ set by insurance companies and healthcare systems, recognizing the diversity of symptoms. Male Excel acknowledges the complexity of hormone optimization and the relevance of symptoms over labs. There is no normal T level.


Personalized Hormone Optimization: We understand that one size doesn’t fit all. Each person is unique, and hormones are complex. Male Excel focuses on optimizing hormones to align with individual needs and goals. When you feel good – life is good. Learn more about optimal hormones.


Age-Related Decline: Our approach addresses natural hormone decline after age 35. Optimizing hormone health after this age helps you lead a healthier and more energetic life. Getting Older is Inevitable. Feeling Older is a choice.


Benefits of Optimal Hormone Levels: Optimizing your testosterone levels leads to improved libido, cardiovascular health, reduced body fat, enhanced mood, better sleep, and greater resilience to stress while reducing the risk of type 2 diabetes and insulin resistance. Optimal hormones are your best route to healthy aging. Learn more about the benefits of testosterone replacement therapy.



Creams Vs. Injections: Whether through cream or injections, the MyExcel protocol works. Both methods deliver results such as enhanced muscle mass, weight loss, and increased energy levels. However, the cream is favored by many, as it boosts DHT levels, balances cholesterol better, and eliminates the need for injections. Testosterone cream or injections, either way, both deliver.

TRT Backed by Science

Studies On the Benefits of TRT: TRT offers numerous health benefits, including improving cardiovascular health, aiding weight loss, reducing diabetes risk, enhancing muscle growth, reducing Alzheimer’s risk, improving cognitive function, enhancing energy levels, libido, and mood, and promoting better sleep. And the evidence proves it. Check out this study to learn more. Controversies and Advances With Testosterone Therapy: A 40-Year Perspective

“Ultimately, we believe that there is considerable scientific and clinical evidence to suggest that testosterone therapy is safe and effective with restoration of physiological levels in men with testosterone deficiency, irrespective of its etiology.”

Traish A. Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return? Investig Clin Urol. 2016 Nov.

TRT Does Not Cause Heart Attacks: All the latest studies clearly show that TRT will not cause heart attacks or strokes. In fact, TRT reduces the risk of cardiovascular disease and heart attack risk. Check out the report ‘No Link Between Testosterone Therapy And CV Risk.’ to learn more.

“Hormonal therapy then, together with adequate physical activity and a healthy lifestyle, might delay the aging process, prevent disability, and contribute to maintain the elderly as well integrated members of society and enable them to enjoy the highest quality of life.”

A. Vermeulen, Androgen Replacement Therapy in the Aging Male—A Critical Evaluation, The Journal of Clinical Endocrinology & Metabolism, Volume 86, Issue 6, 1 June 2001, Pages 2380–2390

TRT and Prostate Cancer Misconceptions: Recent research findings indicate that testosterone treatment does not heighten the risk of prostate cancer; instead, it may even lower the risk of aggressive forms of the disease. This study Testosterone Therapy in Men With Prostate Cancer,” clearly shows no risk.

“Current evidence reveals that high endogenous androgen levels do not increase the risk of a prostate cancer diagnosis. Similarly, testosterone therapy in men with testosterone deficiency does not appear to increase prostate cancer risk or the likelihood of a more aggressive disease at prostate cancer diagnosis.”

Kaplan AL, Hu JC, Morgentaler A, Mulhall JP, Schulman CC, Montorsi F. Testosterone Therapy in Men With Prostate Cancer. Eur Urol. 2016

TRT Does Not Cause Blood Clots: The idea that TRT causes them is entirely unfounded. To this day, no single documented case of a TRT-induced blood clot exists. This study of 35,000 men on TRT should put your mind at rest: Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy.

“It is reassuring that as far as we can determine, no testosterone associated thromboembolic events have been reported to date.”.

Rhoden EL, Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. The New England journal of medicine. 2004;350(5):482-492.

TRT is a Health Journey: TRT should not be seen as a quick fix but as a component of a holistic approach to health. It works best when combined with a healthy diet and exercise. Studies show that TRT, combined with Lifestyle changes, is an effective tool for combating many age-related diseases and obesity. Check out this study for solid proof. Testosterone and weight loss: the evidence which highlights these key points:

  • Long-term testosterone therapy in men with testosterone deficiency improves body composition and quality of life.
  • Long-term testosterone therapy in obese men with testosterone deficiency ameliorates all metabolic syndrome (MetS) components.
  • Long-term testosterone therapy in men with testosterone deficiency, with or without lifestyle modifications, may prove very effective and useful in the management of obesity.

Traish AM. Testosterone and weight loss: the evidence. Curr Opin Endocrinol Diabetes Obes. 2014 Oct

The Obstacles

Primary Care Doctors’ Lack of Expertise:

Many primary care doctors lack the necessary training and expertise to understand TRT fully. They often only prescribe it when testosterone levels fall into the clinical ‘low T’ category, missing the opportunity for preventative use.

Insurance companies typically only cover TRT when testosterone levels are clinically low. This coverage model discourages doctors from diagnosing from symptoms and recommending TRT for preventative use.

Testosterone replacement therapy often gets negative press due to misunderstandings and associations with athletes and bodybuilders. This is not the same as therapeutic testosterone replacement therapy.

Large pharmaceutical companies have historically discredited bioidentical hormone replacement therapy (BHRT). They cannot patent bioidentical hormones, so BHRT doesn’t offer the same revenue potential as synthetic alternatives.

Large pharmaceutical companies profit from treating age-related diseases rather than preventing them. Hormone replacement therapy, including testosterone, can help people stay well – a healthy aging population means less money for big pharma companies.

The United States pays the highest medicine prices globally, yet its life expectancy is lower than other wealthy countries. Promoting HRT and a healthy lifestyle could save significant amounts of money in healthcare costs.

The argument that supplementing testosterone is unnatural contradicts the fact that many people readily take synthetic drugs like statins and Viagra for various health issues. BHRT is about replacing what’s missing in the body as people age. We believe in embracing what your body needs.

Our commitment to personalized hormone optimization, daily injections for maximum benefit, and the holistic approach to thyroid health sets us apart. We emphasize the importance of estrogen in men’s well-being and challenge the conventional “normal range” set by insurance companies. With Male Excel, there’s no one-size-fits-all approach, and we believe that feeling your best is the ultimate goal.

Studies and References

1. Morales, Alvaro, et al. “Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline.” Cmaj 187.18 (2015): 1369-1377.


2. Carruthers, Malcolm. “The paradox dividing testosterone deficiency symptoms and androgen assays: a closer look at the cellular and molecular mechanisms of androgen action.” The journal of sexual medicine 5.4 (2008): 998-1012.

3. Carruthers, Malcolm. “The diagnosis of late life hypogonadism.” The Aging Male 11.1 (2008): 45-46.


4. Vermeulen, Alex. “Androgen replacement therapy in the aging male—a critical evaluation.” The Journal of Clinical Endocrinology & Metabolism 86.6 (2001): 2380-2390.


5. Bankhead, C (2014).  Need more than Lab Test to determine Low T. Urology.

Paduch, Darius A., et al. “The laboratory diagnosis of testosterone deficiency.” Urology 83.5 (2014): 980-988.


6. Carruthers, Malcolm, Tom R. Trinick, and Michael J. Wheeler. “The validity of androgen assays.” The Aging Male 10.3 (2007): 165-172.


7. Morgentaler, Abraham. “Controversies and advances with testosterone therapy: a 40-year perspective.” Urology 89 (2016): 27-32.


8. Morgentaler, A. (2015).  Study: No link between testosterone therapy and CV risk.  Consultant


9. Morgentaler, Abraham, et al. “Testosterone therapy and cardiovascular risk: advances and controversies.” Mayo Clinic Proceedings. Vol. 90. No. 2. Elsevier, 2015.


10. Sharma, Rishi, et al. “Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.” European Heart Journal 36.40 (2015): 2706-2715.


11. Morgentaler A, Miner MM, Caliber M, Guay AT, Khera M, Traish AM. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015 Feb;90(2):224-51. doi: 10.1016/j.mayocp.2014.10.011. PMID: 25636998.


12. Kaplan AL, Hu JC, Morgentaler A, Mulhall JP, Schulman CC, Montorsi F. Testosterone Therapy in Men With Prostate Cancer. Eur Urol. 2016 May;69(5):894-903. doi: 10.1016/j.eururo.2015.12.005. Epub 2015 Dec 21. PMID: 26719015; PMCID: PMC5000551.


13. Holmegard HN, Nordestgaard BG, Schnohr P, Tybjaerg-Hansen A, Benn M. Endogenous sex hormones and risk of venous thromboembolism in women and men. J Thromb Haemost. 2014;12(3):297-305. doi: 10.1111/jth.12484. PMID: 24329981.

See More